Abstract:Purpose: To assess noninferiority of the safety and effectiveness of the Altis® Single Incision Sling (SIS) with standard midurethral transobturator and/or retropubic slings through 36 months in a prospective, longitudinal, nonrandomized US Food and Drug Administration (FDA) 522 cohort study. Materials and methods: Adult females with confirmed predominant stress urinary incontinence (UI) through cough stress test (CST) or urodynamics and failed two noninvasive incontinence therapies. Effectiveness endpoints included objective dryness, negative CST, adverse events, and revision/resurgery through 36 months. The primary effectiveness endpoint was reduction from baseline in 24-h pad weight of ≥50% at 6 months, as requested by the FDA, and is included as a study point in this paper. Primary safety endpoint was rate of related serious adverse events (SAE) through 36 months. Noninferiority margins of 15% and 10% were prespecified for the effectiveness and safety endpoints. Due to the observational nature of the cohort study, a propensity methodology was conducted to assess the effect of potential confounding variables on the primary endpoints between groups. Results: Three hundred fifty-five women underwent the sling procedure (n = 184 Altis; n = 171 Comparator). One hundred fourty (76%) Altis subjects and 101 (59%) Comparator subjects completed follow-up through 36 months. At 36 months, for the effectiveness endpoint, the difference in proportions of -0.005 for Altis versus Comparator (95% confidence interval [CI]: -0.102 to 0.092) was statistically significant (p = 0.002), supporting the hypothesis that Altis is noninferior to Comparator. Furthermore, both groups demonstrated high objective efficacy; in the Altis arm n = 99 (81.8%) subjects were a success, and in the Comparator arm, n = 79 (82.3%) subjects were a success. Additionally, regarding the CST, Altis was found to be noninferior to the Comparator at every study visit, and the rate of negative CST remained above 80% for both groups (p < 0.001). At 36 months, Altis (n = 2; 1.1%) and Comparator (n = 4; 2.3%) subjects experienced a device and/or procedure-related SAE. The difference in proportions of 0.013 for Altis versus Comparator (95% CI: -0.023 to 0.048) was statistically significant (p < 0.001), demonstrating that Altis is noninferior to Comparator with respect to the primary safety endpoint throughout the study. There were 62 (36.3%) retropubic midurethral slings (RMUS), 96 (56.1%) transobturator midurethral slings (TMUS), and 13 (7.6%) SIS slings in the Comparator group. For the 36 month effectiveness endpoint, assessing the noninferiority of Altis versus RMUS and Altis versus TMUS, 99 (81.8%) Altis and 37 (90.2%) RMUS were a success, trending toward statistical significance, however, it cannot be determined to be noninferior (p = 0.092). Ninty-nine (81.8%) Altis and 33 (71.7%) TMUS were a success; this was statistically significant (p < 0.001), demonstrating Altis was noninferior to TMUS. Rates of negative CST were 122 (87.1%) Altis, 40 (93.0%) RMUS (p < 0.001), and 44 (91.7%) TMUS (p < 0.001). CST demonstrated that Altis was noninferior to RMUS and Altis was noninferior to TMUS at 36 months. Conclusion: Altis single-incision sling was noninferior to standard midurethral sling for treatment of stress UI, throughout the study and at 36 months. Furthermore, adverse event rates were low.

Short-term outcomes of the Adjustable Single-Incision Sling for the treatment of stress urinary incontinence

Adjustable Single-Incision Mini-Slings (ajust®) Versus Other Slings in Surgical Management of Female Stress Urinary Incontinence: a Meta-Analysis of Effectiveness and Complications.

Comparison of Various Methods in the Sling Adjustment in Stress Urinary Incontinence Surgery

A New Surgery for Recurrent or Persist Stress Urinary Incontinence in Females after Primary Mid-Urethral Slings.

An Modified Vaginal Mesh Procedure for the Female Persistent or Recurrent Stress Urinary Incontinence after Initial Synthetic Mid-Urethral Slings Operation

Clinical study of a Tong's modified TVT-O treatment of female stress urinary incontinence

Patient Satisfaction and QoL in SUI: Results With Single-Incision or Full-Length Slings

Management of female stress urinary incontinence with single-incision mini-sling (Altis®): 36 month multicenter outcomes

Study on the Effectiveness of Transobturator Tension-Free Tape and Retropubic-Mid-urethral Sling in the Treatment of Stress Urinary Incontinence

Analysis on the Treatment of Female Stress Urinary Incontinence with Intravaginal Slingplasty

Minimally Invasive Treatment of Stress Urinary Incontinence in Women: A Prospective Comparative Analysis between Bulking Agent and Single-Incision Sling

[Analysis of Outcomes of Tension-Free Mid-Urethral Sling Procedure in Women with Mixed Urinary Incontinence].

Urethral Suspension with Artificial Sling Fixed in Pubis or Abdominal Wall for the Treatment of Female Stress Urinary Incontinence

A comparative study on two surgical procedures in treatment of stress urinary incontinence in old women

Analysis on the treatment of elderly woman stress urinary incontinence with operation

The Assessment Of Mid-Urethral Sling On The Sexual Function Of Patient'S Spouse Using A New Self-Administered Questionnaire

Clinical research of a butterfly shaped mesh in the treatment of stress urinary incontinence]

A Retrospective Cohort Single-Institution Study

The Efficacy and Safety of Single-Incision Mini-Slings for Stress Urinary Incontinence: A Network Meta-Analysis

The Clinical Efficacy Of Needleless Sling Technique And Tot In The Treatment Of Female Stress Urinary Incontinence: A Prospective Randomized Controlled Trial

Efficacy of Pelvic Floor Ultrasound for Assessing Transobturator Tape Sling Procedure.